
GSK data at ASCO and EHA showcase latest research and innovation across the oncology portfolio
Latest data on Blenrep (belantamab mafodotin) combinations underscore the potential to transform treatment of 2L+ multiple myeloma New analyses from MOMENTUM and SIMPLIFY-1 trials at EHA emphasise importance of early intervention with Omjjara (momelotinib) …